Meridian
Pharma Partners
Meridian Pharma Partners works at the intersection of pharmaceutical innovation, manufacturing execution, and strategic transactions — carrying proprietary drug IP through development, production, and the deals that move it into the right hands.
Bringing a proprietary pharmaceutical product to market takes more than a formula — it takes a partner who executes reliably, documents rigorously, and scales predictably. That is the gap Meridian fills, from the lab bench to the cap table.
Most proprietary drug IP never reaches the patients it was developed for. The formula clears the science, but stalls on the execution — a manufacturing relationship that can't hold specification at volume, documentation that doesn't satisfy a downstream partner's due diligence, or a corporate structure that no longer fits where the asset needs to go next.
Meridian sits at that pressure point. We work directly with IP holders to secure exclusive rights around a specific product, then stay involved through development, production, and — where it serves the asset — the transaction that moves it to its next owner or partner. One relationship, carried the whole way.
How We Work
We evaluate the product, the IP position, and the regulatory pathway, then structure exclusive rights around it.
We match the product to the right manufacturing relationship and set the technical, quality, and commercial terms.
We carry the product through feasibility, process development, and GMP production with full batch documentation.
We manage the move to commercial volume and, where it's the right next step, the M&A or divestiture that follows.
What We Do
We secure exclusive rights around specific proprietary products, then coordinate every stage of production through our manufacturing relationships — from initial feasibility and process development through full-scale commercial output.
We guide a product from early formulation work through the regulatory, technical, and go-to-market steps that turn a proprietary compound into a product patients and providers can actually access.
We advise on the mergers, acquisitions, and portfolio moves that shape how pharmaceutical assets and manufacturing relationships change hands, bringing the same discipline to deal structuring that we bring to production.
We help companies move ANDAs off their books and into the hands of partners better positioned to manufacture and commercialize them, matching each asset to where it can perform best.
Our Approach
Manufacturing partnerships are structured around defined, exclusive rights — so IP holders know their proprietary product isn't shared across competing parties.
Rigorous testing, batch traceability, and complete documentation — certificates of analysis, batch records, and the regulatory paperwork our partners depend on.
We manage the transition from early-stage production runs to full commercial volume, with an emphasis on lot-to-lot consistency rather than one-off manufacturing.
The same discipline we bring to manufacturing carries into M&A and ANDA transitions — matching assets to the partners best equipped to run with them.
Who We Serve
Meridian is built for pharmaceutical IP holders and asset owners who need a manufacturing path that's disciplined, well-documented, and built to scale — without building and managing that infrastructure themselves.
Where a deal is the right next step, we bring a transaction partner who understands the regulatory and operational realities behind it. We handle the operational complexity of getting a product produced correctly, and the strategic work of getting assets into the right hands, so our partners can focus on the market.
Meridian
Pharma Partners
Get In Touch
Tell us about the product, the IP position, and what you need — manufacturing, development, a divestiture, or all three. We'll respond directly.
info@meridianpharmapartners.com